CTSB is intimately associated with metabolic disorders such as type 2 diabetes, atherosclerosis, cardiac reperfusion injury, and chronic kidney disease through regulating the NLRP3 inflammasome in the cytoplasm (Yadati et al. 2020). Here, NLRP3 is linked to atherosclerosis.